Last Updated: 10/28/16
Phase 2 N01 Program
The Phase 2 N01 Program is a CTEP-CIP collaboration includes 7 contractors, most of whom consist of multi-institutional consortia, and includes a total of 22 NCI-designated Cancer Centers. These sites carry out early clinical trials with CTEP and CIP-held IND agents, with an emphasis on phase 2 trials, but including phase 1 trials as well. These trials include the evaluation of novel imaging agents and methods to enhance the evaluation of novel therapeutics.
For more information on the Phase 2 N01 Program and the list of approved contractors under this program, please see the CTEP Initiatives page at http://ctep.cancer.gov/industryCollaborations/default.htm#initiatives.
Reports & Publications
Specialized Initiatives
- Phase 2 N01 Program
- Network for Translational Research
- Small Animal Imaging Resource Program (SAIRP)
- Current SAIRP Institutions and Principal Investigators
- University of Michigan
- M D Anderson Cancer Center
- University of Pennsylvania
- Memorial Sloan-Kettering Cancer Center
- Washington University
- Duke University
- Johns Hopkins University
- Massachusetts General Hospital
- Vanderbilt University
- University of California, Los Angeles
- Case Western Reserve University
- University of California at Davis
- University of Texas Southwestern
- ICMIC Institutions
- DCIDE